Skip to main content
Premium Trial:

Request an Annual Quote

Biosimilars ... That's Catchy

An article from the Wall Street Journal earlier this week points out the growing controversy over how to deal with (and whether to allow) generic versions of biotech drugs. Biotech companies argue that there's no way to engineer and deliver a generic version without all the same safety testing and regulations that went into making the original, but that hasn’t stopped companies from starting work on it -- or legislators from proposing bills allowing for these kinds of generics.


The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.